Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-02 09:20 am Purchase | 2023-12-31 | 13G | NEUROPACE INC NPCE | Soleus Private Equity Fund I, L.P. | 2,432,768 9.300% | 63,765 (+2.69%) | Filing History |
| 2023-02-14 4:48 pm Unchanged | 2022-12-31 | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 4,012,281 16.100% | 0 (Unchanged) | Filing History |
| 2023-02-14 08:22 am Purchase | 2022-12-31 | 13G | NEUROPACE INC NPCE | Soleus Private Equity Fund I, L.P. | 2,369,003 9.500% | 60,000 (+2.60%) | Filing History |
| 2023-02-10 1:12 pm Purchase | 2022-12-30 | 13G | NEUROPACE INC NPCE | Morgan Stanley MS | 2,188,593 8.800% | 2,188,593 (New Position) | Filing History |
| 2023-02-09 12:01 pm Purchase | 2023-02-09 | 13G | NEUROPACE INC NPCE | FMR LLC | 1,449,926 5.822% | 1,449,926 (New Position) | Filing History |
| 2022-11-23 5:11 pm Purchase | 2022-11-21 | 13D | NEUROPACE INC NPCE | Accelmed Partners II L.P. | 4,432,948 17.800% | 390,291 (+9.65%) | Filing History |
| 2022-11-21 07:00 am Purchase | 2022-11-18 | 13D | NEUROPACE INC NPCE | Accelmed Partners II L.P. | 4,042,657 16.200% | 4,042,657 (New Position) | Filing History |
| 2022-10-07 4:49 pm Purchase | 2021-12-31 | 13G | NEUROPACE INC NPCE | KCK LTD. | 5,621,111 22.990% | 5,621,111 (New Position) | Filing History |
| 2022-02-11 4:35 pm Unchanged | 2021-12-31 | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 4,012,281 16.500% | 0 (Unchanged) | Filing History |
| 2022-02-10 5:00 pm Purchase | 2021-12-31 | 13G | NEUROPACE INC NPCE | Soleus Private Equity Fund I, L.P. | 2,309,003 9.500% | 473,663 (+25.81%) | Filing History |
| 2022-01-13 4:23 pm Sale | 2021-12-31 | 13G | NEUROPACE INC NPCE | Medtronic plc MDT | 965,936 3.970% | -300,000 (-23.70%) | Filing History |
| 2021-11-01 5:16 pm Purchase | 2021-04-26 | 13G | NEUROPACE INC NPCE | Soleus Private Equity Fund I, L.P. | 1,835,340 7.600% | 1,835,340 (New Position) | Filing History |